NCT00003542View on ClinicalTrials.gov

Interferon Alfa in Treating Patients With Advanced Kidney Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

pegylated interferon alfa

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003542 - Interferon Alfa in Treating Patients With Advanced Kidney Cancer | Biotech Hunter | Biotech Hunter